DE2300367A1 - Alkenyl- und alkinylsubstituierte xanthoncarbonsaeuren - Google Patents

Alkenyl- und alkinylsubstituierte xanthoncarbonsaeuren

Info

Publication number
DE2300367A1
DE2300367A1 DE2300367A DE2300367A DE2300367A1 DE 2300367 A1 DE2300367 A1 DE 2300367A1 DE 2300367 A DE2300367 A DE 2300367A DE 2300367 A DE2300367 A DE 2300367A DE 2300367 A1 DE2300367 A1 DE 2300367A1
Authority
DE
Germany
Prior art keywords
formula
carboxylic acid
compound according
xanthone
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2300367A
Other languages
German (de)
English (en)
Inventor
John H Fried
Ian T Harrison
Jurg R Pfister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of DE2300367A1 publication Critical patent/DE2300367A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DE2300367A 1972-09-25 1973-01-05 Alkenyl- und alkinylsubstituierte xanthoncarbonsaeuren Pending DE2300367A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00291618A US3818040A (en) 1972-09-25 1972-09-25 Alkenyl and alkynyl substituted xanthone carboxylic acid compounds

Publications (1)

Publication Number Publication Date
DE2300367A1 true DE2300367A1 (de) 1974-04-25

Family

ID=23121062

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2300367A Pending DE2300367A1 (de) 1972-09-25 1973-01-05 Alkenyl- und alkinylsubstituierte xanthoncarbonsaeuren

Country Status (14)

Country Link
US (1) US3818040A (cg-RX-API-DMAC10.html)
JP (1) JPS4969672A (cg-RX-API-DMAC10.html)
AR (1) AR195514A1 (cg-RX-API-DMAC10.html)
AT (1) AT325040B (cg-RX-API-DMAC10.html)
AU (1) AU464832B2 (cg-RX-API-DMAC10.html)
BE (1) BE793865A (cg-RX-API-DMAC10.html)
DE (1) DE2300367A1 (cg-RX-API-DMAC10.html)
ES (1) ES410419A1 (cg-RX-API-DMAC10.html)
FR (1) FR2199977B1 (cg-RX-API-DMAC10.html)
GB (1) GB1399168A (cg-RX-API-DMAC10.html)
IL (1) IL40899A (cg-RX-API-DMAC10.html)
NL (1) NL7300531A (cg-RX-API-DMAC10.html)
SE (1) SE387120B (cg-RX-API-DMAC10.html)
ZA (1) ZA728288B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284288A1 (en) * 1987-03-20 1988-09-28 Allergan, Inc Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304720A (en) * 1980-04-30 1981-12-08 Merck & Co., Inc. Fluorescein esters and ethers and the preparation thereof
MXPA02008778A (es) * 2000-03-09 2005-06-20 Gw Pharma Ltd Composiciones farmaceuticas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284288A1 (en) * 1987-03-20 1988-09-28 Allergan, Inc Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity

Also Published As

Publication number Publication date
AU464832B2 (en) 1975-09-11
US3818040A (en) 1974-06-18
IL40899A0 (en) 1973-01-30
IL40899A (en) 1975-06-25
GB1399168A (en) 1975-06-25
NL7300531A (cg-RX-API-DMAC10.html) 1974-03-27
ES410419A1 (es) 1976-05-01
AU5012372A (en) 1974-06-20
FR2199977B1 (cg-RX-API-DMAC10.html) 1976-03-05
SE387120B (sv) 1976-08-30
AR195514A1 (es) 1973-10-15
ZA728288B (en) 1974-07-31
FR2199977A1 (cg-RX-API-DMAC10.html) 1974-04-19
AT325040B (de) 1975-09-25
JPS4969672A (cg-RX-API-DMAC10.html) 1974-07-05
BE793865A (fr) 1973-07-10

Similar Documents

Publication Publication Date Title
DE3144183A1 (de) "neue derivate des nortropans und granatans, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel"
DE3346869A1 (de) Neue labdan-derivate, verfahren zu ihrer herstellung und labdan-derivate enthaltende pharmazeutische zusammensetzungen
CH625243A5 (cg-RX-API-DMAC10.html)
DE2736784A1 (de) N-substituierte und nichtsubstituierte hexahydro-6-canthinonderivate, verfahren zum herstellen derselben und diese derivate enthaltende pharmazeutische zusammensetzung
DE2802493A1 (de) Neue imidazochinoline und deren salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE3103372A1 (de) Neue indanyl-derivate, ihre herstellung und verwendung
DE2263100C2 (de) 5,5-Dimethyl-8-(3-methyl-2-octyl)-10-[4-(piperidino)-butyryloxy]-2-(2-propinyl)-1,2,3,4-tetrahydro-5H-[1]-benzopyrano[3,4-d]pyridin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel
CH617699A5 (cg-RX-API-DMAC10.html)
DE2855064C2 (de) 2-Aminomethyl-6-jodphenol-Derivate und Verfahren zu deren Herstellung
DE2300367A1 (de) Alkenyl- und alkinylsubstituierte xanthoncarbonsaeuren
CH616935A5 (en) Process for the preparation of chromone derivatives
DE2234255B2 (de) Xanthon-2-carbonsäuren, deren pharmakologisch nicht toxische Salze sowie Alkylester mit 1 bis 5 Kohlenstoffatomen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel
DE2336671A1 (de) Oxyessigsaeureaether von o-thymotinsaeureestern
DE3208079A1 (de) Neue indanyl-derivate, ihre herstellung und verwendung
DD145266A5 (de) Verfahren zur herstellung von 6-methoxy-2-acetylnaphthalinoxim-derivaten
CH637957A5 (de) Verfahren zur herstellung neuer pyridobenzodiazepinone und ihrer salze.
DE2445002C2 (de) N,N'-(Pyridin-diyl)-dioxamidsäurederivate und deren pharmazeutisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und dieselben enthaltende pharmazeutische Mittel
DE2251872C3 (de) Salze des N- [(5-Carboxy-methoxy-2-phenyl-ybenzopyron-7-yl)-oxyacetyl] -tetrahydropapaverins, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2433837C3 (de) 1-Amidino-3-phenyl-harnstoffe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende therapeutische Zubereitungen
EP0113911B1 (de) Pyrido-triazolochinazoline, ihre Herstellung und Verwendung
DE1695955A1 (de) Tertiaere 1,3-Aminoalkohole und Verfahren zu ihrer Herstellung
DE2234250A1 (de) Neue substituierte xanthoncarbonsaeureverbindungen
CH626056A5 (cg-RX-API-DMAC10.html)
CH513806A (de) Verfahren zur Herstellung von tricyclischen Verbindungen
DE2157694C3 (de) Phenylessigsäurederivate, Verfahren zu ihrer Herstellung und Phenylessigsäurederivate enthaltende pharmazeutische Zubereitungen